Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1324 | 2.290 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 947 | 2.020 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 905 | 1.640 |
Why?
|
| Gait | 6 | 2021 | 363 | 1.310 |
Why?
|
| Hippocampus | 6 | 2020 | 222 | 1.260 |
Why?
|
| Exercise | 6 | 2021 | 305 | 1.140 |
Why?
|
| Cognition | 10 | 2022 | 1104 | 1.080 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 1774 | 0.990 |
Why?
|
| Aged, 80 and over | 28 | 2022 | 4055 | 0.970 |
Why?
|
| Aging | 8 | 2021 | 1290 | 0.930 |
Why?
|
| Postural Balance | 3 | 2021 | 97 | 0.860 |
Why?
|
| Independent Living | 5 | 2021 | 265 | 0.840 |
Why?
|
| Postmortem Changes | 2 | 2016 | 25 | 0.820 |
Why?
|
| Neuropathology | 3 | 2021 | 73 | 0.810 |
Why?
|
| Male | 35 | 2022 | 12453 | 0.710 |
Why?
|
| Female | 35 | 2022 | 12677 | 0.700 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 35 | 0.690 |
Why?
|
| White Matter | 5 | 2018 | 116 | 0.680 |
Why?
|
| Humans | 47 | 2022 | 22848 | 0.650 |
Why?
|
| Aged | 25 | 2022 | 7669 | 0.600 |
Why?
|
| Autopsy | 9 | 2021 | 275 | 0.590 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 57 | 0.580 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 40 | 0.570 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 84 | 0.540 |
Why?
|
| Motor Activity | 1 | 2018 | 239 | 0.510 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 643 | 0.500 |
Why?
|
| Thalamus | 3 | 2021 | 13 | 0.450 |
Why?
|
| Atrophy | 3 | 2021 | 74 | 0.450 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 149 | 0.430 |
Why?
|
| Knee Joint | 1 | 2019 | 688 | 0.420 |
Why?
|
| Accelerometry | 4 | 2021 | 69 | 0.380 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 60 | 0.370 |
Why?
|
| Walking | 4 | 2022 | 207 | 0.370 |
Why?
|
| Neuroimaging | 3 | 2021 | 108 | 0.360 |
Why?
|
| Walking Speed | 2 | 2021 | 34 | 0.340 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1122 | 0.330 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 177 | 0.330 |
Why?
|
| Gray Matter | 3 | 2021 | 44 | 0.330 |
Why?
|
| RNA, Messenger | 2 | 2022 | 254 | 0.310 |
Why?
|
| Formaldehyde | 1 | 2009 | 5 | 0.310 |
Why?
|
| Cohort Studies | 8 | 2020 | 1621 | 0.290 |
Why?
|
| Parkinson Disease | 4 | 2021 | 556 | 0.290 |
Why?
|
| Temporal Lobe | 2 | 2020 | 79 | 0.290 |
Why?
|
| Brain Mapping | 3 | 2017 | 133 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 182 | 0.280 |
Why?
|
| Dementia | 2 | 2022 | 484 | 0.260 |
Why?
|
| Organ Size | 3 | 2015 | 88 | 0.240 |
Why?
|
| Nerve Net | 2 | 2021 | 34 | 0.210 |
Why?
|
| Sclerosis | 3 | 2019 | 58 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 982 | 0.210 |
Why?
|
| Transcriptome | 2 | 2022 | 72 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 76 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2019 | 138 | 0.200 |
Why?
|
| Tremor | 2 | 2021 | 65 | 0.200 |
Why?
|
| Proteome | 1 | 2022 | 30 | 0.190 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 7 | 0.180 |
Why?
|
| Proteomics | 1 | 2022 | 69 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 106 | 0.180 |
Why?
|
| Motor Skills | 1 | 2021 | 38 | 0.180 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 6 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 86 | 0.180 |
Why?
|
| Neuropeptides | 2 | 2019 | 24 | 0.170 |
Why?
|
| Hand Strength | 1 | 2021 | 34 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 26 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 166 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2021 | 26 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2017 | 807 | 0.170 |
Why?
|
| Cognitive Aging | 1 | 2021 | 70 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 96 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 118 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 50 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 79 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 4 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 5 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 11 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 100 | 0.160 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 9 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 16 | 0.160 |
Why?
|
| Memory | 3 | 2017 | 241 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 119 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 66 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 8 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 35 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2019 | 104 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 77 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 223 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 54 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 21 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 31 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.140 |
Why?
|
| Linear Models | 2 | 2016 | 205 | 0.140 |
Why?
|
| Neurons | 1 | 2019 | 259 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 25 | 0.130 |
Why?
|
| Femur | 1 | 2020 | 349 | 0.130 |
Why?
|
| Plasmacytoma | 1 | 2016 | 7 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 79 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 126 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 144 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 21 | 0.120 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 63 | 0.120 |
Why?
|
| Algorithms | 2 | 2019 | 305 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 270 | 0.120 |
Why?
|
| Adult | 8 | 2021 | 6584 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 1721 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 65 | 0.120 |
Why?
|
| Joint Instability | 1 | 2019 | 363 | 0.110 |
Why?
|
| Locomotion | 1 | 2014 | 21 | 0.110 |
Why?
|
| Middle Aged | 6 | 2021 | 7555 | 0.100 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 357 | 0.100 |
Why?
|
| Shoulder Joint | 1 | 2019 | 642 | 0.100 |
Why?
|
| Memory, Episodic | 1 | 2011 | 98 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 36 | 0.090 |
Why?
|
| Mortality | 2 | 2021 | 75 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 1942 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 5 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 381 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 808 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 147 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 227 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 146 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 588 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 558 | 0.060 |
Why?
|
| Depression | 2 | 2017 | 375 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 12 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 27 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 62 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 93 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 25 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2021 | 39 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 174 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 95 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 77 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 9 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 7 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 18 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 12 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 127 | 0.040 |
Why?
|
| Software | 1 | 2019 | 57 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 49 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 390 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 85 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 713 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 685 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 10 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 657 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 554 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 34 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 36 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 649 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2018 | 210 | 0.040 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 140 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 5 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 32 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 630 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 35 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 53 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 173 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 71 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 30 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 539 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 233 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 121 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1494 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 233 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 301 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1528 | 0.030 |
Why?
|
| United States | 1 | 2021 | 1726 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 73 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 113 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 17 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 18 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 207 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 290 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 40 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 140 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 1775 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 401 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 344 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3062 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 549 | 0.020 |
Why?
|